➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Colorcon
Baxter
Medtronic
Dow

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Litigation Details for Palomar Technologies, Inc. v. MRSI Systems, LLC (D. Mass. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Palomar Technologies, Inc. v. MRSI Systems, LLC (D. Mass. 2018)

Docket   Start Trial Date Filed 2018-02-06
Court District Court, D. Massachusetts Date Terminated
Cause 28:1338 Patent Infringement Assigned To
Jury Demand Referred To
Patents 10,004,788; 10,005,954; 10,010,585; 10,010,611; 10,010,612; 10,011,584; 10,011,660; 10,017,768; 10,022,317; 10,022,427; 10,028,962; 10,035,788; 10,035,838; 10,036,759; 10,045,532; 10,045,943; 10,064,911; 10,065,100; 10,071,051; 10,071,953; 10,071,962; 10,094,836; 10,180,430; 10,208,073; 10,208,101; 10,220,042; 10,220,047; 10,220,048; 10,220,049; 10,220,072; 10,220,090; 10,254,564; 10,256,050; 10,322,085; 10,327,481; 10,344,765; 10,376,579; 10,407,393; 10,413,615; 10,450,561; 10,450,613; 10,466,250; 10,525,022; 10,525,045; 10,525,053; 10,525,057; 10,532,028; 10,532,051; 10,532,056; 10,532,091; 10,532,096; 10,561,716; 10,561,723; 10,584,178; 6,008,437; 6,010,911; 6,032,954; 6,036,610; 6,051,561; 6,077,178; 6,100,450; 6,113,096; 6,180,565; 6,242,473; 6,316,475; 6,413,776; 6,525,242; 6,585,943; 6,617,148; 6,660,477; 6,716,121; 6,723,012; 6,723,556; 6,759,064; 6,759,069; 6,759,079; 6,790,837; 6,881,208; 6,881,722; 6,919,348; 6,920,715; 6,953,120; 7,001,282; 7,009,037; 7,014,610; 7,017,427; 7,038,071; 7,041,450; 7,045,096; 7,090,085; 7,090,830; 7,091,004; 7,101,584; 7,178,823; 7,220,585; 7,223,584; 7,223,837; 7,225,584; 7,232,919; 7,250,271; 7,256,216; 7,344,716; 7,393,533; 7,446,124; 7,566,714; 7,566,816; 7,585,837; 7,585,943; 7,610,097; 7,612,030; 7,612,035; 7,612,073; 7,612,208; 7,615,046; 7,709,022; 7,709,039; 7,709,477; 7,714,185; 7,723,573; 7,727,090; 7,727,566; 7,759,079; 7,759,098; 7,759,376; 7,772,002; 7,772,011; 7,772,178; 7,772,219; 7,776,007; 7,776,525; 7,776,838; 7,790,954; 7,833,148; 7,833,765; 7,834,240; 7,838,009; 7,838,027; 7,838,053; 7,838,564; 7,919,115; 7,939,063; 7,939,585; 7,939,714; 7,943,178; 7,943,788; 7,960,111; 8,003,096; 8,013,113; 8,014,953; 8,016,788; 8,021,660; 8,022,064; 8,029,768; 8,030,064; 8,030,545; 8,043,250; 8,048,017; 8,048,409; 8,053,427; 8,063,029; 8,063,031; 8,067,025; 8,067,437; 8,070,607; 8,071,090; 8,071,113; 8,071,525; 8,071,556; 8,071,613; 8,071,723; 8,075,739; 8,075,919; 8,092,834; 8,097,739; 8,101,564; 8,101,593; 8,112,609; 8,124,586; 8,129,586; 8,216,091; 8,217,012; 8,217,020; 8,217,033; 8,217,035; 8,217,057; 8,217,225; 8,221,566; 8,232,327; 8,242,095; 8,242,112; 8,256,028; 8,316,446; 8,317,911; 8,409,038; 8,450,100; 8,466,035; 8,481,006; 8,481,043; 8,481,064; 8,481,067; 8,545,830; 8,545,881; 8,586,045; 8,586,078; 8,586,103; 8,586,533; 8,586,610; 8,609,095; 8,609,112; 8,609,113; 8,609,722; 8,613,950; 8,716,001; 8,716,225; 8,716,271; 8,722,019; 8,722,021; 8,722,037; 8,722,038; 8,722,047; 8,722,085; 8,722,090; 8,759,043; 8,759,093; 8,759,282; 8,759,316; 8,759,327; 8,765,134; 8,772,030; 8,790,881; 8,822,012; 8,900,565; 8,911,768; 8,927,607; 8,939,943; 8,939,962; 8,962,010; 8,962,012; 8,962,028; 8,962,034; 8,962,593; 9,002,656; 9,005,613; 9,006,223; 9,006,256; 9,011,943; 9,012,437; 9,016,221; 9,020,056; 9,023,790; 9,023,881; 9,033,830; 9,034,612; 9,034,822; 9,050,322; 9,051,561; 9,056,051; 9,056,057; 9,056,100; 9,067,112; 9,067,113; 9,072,759; 9,072,836; 9,079,953; 9,085,565; 9,085,709; 9,095,615; 9,095,739; 9,096,838; 9,101,545; 9,101,585; 9,101,660; 9,102,759; 9,115,407; 9,133,464; 9,161,919; 9,161,953; 9,175,009; 9,175,017; 9,175,033; 9,175,067; 9,216,178; 9,216,223; 9,217,020; 9,217,031; 9,220,282; 9,220,584; 9,220,759; 9,220,962; 9,242,006; 9,322,008; 9,322,025; 9,322,034; 9,322,048; 9,327,023; 9,327,028; 9,327,033; 9,327,175; 9,393,203; 9,408,393; 9,409,850; 9,427,012; 9,427,477; 9,446,133; 9,446,148; 9,464,071; 9,464,133; 9,464,136; 9,481,716; 9,481,850; 9,511,121; 9,532,954; 9,533,044; 9,533,102; 9,533,776; 9,561,066; 9,561,073; 9,561,175; 9,561,177; 9,561,208; 9,566,317; 9,573,962; 9,585,838; 9,585,920; 9,586,083; 9,586,111; 9,586,960; 9,593,066; 9,593,100; 9,610,356; 9,610,409; 9,610,430; 9,615,965; 9,617,344; 9,617,464; 9,656,954; 9,657,078; 9,657,093; 9,657,104; 9,657,271; 9,788,950; 9,823,256; 9,834,586; 9,838,225; 9,850,070; 9,850,473; 9,919,033; 9,920,033; 9,920,254; 9,943,096; 9,943,573; 9,950,039; 9,950,042; 9,950,049; 9,950,112; 9,962,466
Link to Docket External link to docket
Biologic Drugs cited in Palomar Technologies, Inc. v. MRSI Systems, LLC

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Palomar Technologies, Inc. v. MRSI Systems, LLC (D. Mass. 2018)

Date Filed Document No. Description Snippet Link To Document
2020-05-04 765 Memorandum & Order Page 13 of 32 The Ueno patent, U.S. Patent No. 7,020,953, was issued on April 4, 2006. It was…Kramer IP used for its search. (Tr. 2:113-14; see ‘953 Patent at [57]). Kramer surely came close to Ueno; … more than ten million of patents, and because there are also millions of foreign patents and technical…applicant. (Tr. 3:10). He would also look at the file history of the patent. (Tr. 3:10). Finally, he would…uniformity. (See Tr. 2:71). 10 Case 1:18-cv External link to document
2020-05-28 772 Order on Motion for Summary Judgment AND Order on Motion for Summary Judgment sufficient to demonstrate patent eligibility. Ariosa Diagnostics, Inc. v. Sequenom, Inc., 788 F.3d 1371, 1379 …through 10. The patent’s specification identifies the tool as purely conventional. (’327 Patent, col. …utilize a method that infringes on the ’327 Patent. (Compl. ¶¶ 10-15, ECF 1). B. Procedural Background…conclusion.10 Palomar is correct that much of the recent caselaw in the field has focused on patents addressing…processes. See, e.g., 10 Whether the ’327 Patent actually describes a manufacturing External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Dow
Baxter
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.